Primary angioplasty vs. fibrinolysis in very old patients with acute myocardial infarction: TRIANA (TRatamiento del Infarto Agudo de miocardio eN Ancianos) randomized trial and pooled analysis with previous studies

نویسندگان

  • Héctor Bueno
  • Amadeo Betriu
  • Magda Heras
  • Joaquín J. Alonso
  • Angel Cequier
  • Eulogio J. García
  • José L. López-Sendón
  • Carlos Macaya
  • Rosana Hernández-Antolín
  • Héctor Bueno
  • Rosana Hernández-Antolín
  • Joaquín J. Alonso
  • Amadeo Betriu
  • Angel Cequier
  • Eulogio J. García
  • Magda Heras
  • José L. López-Sendón
  • Carlos Macaya
  • José Azpitarte
  • Ginés Sanz
  • Angel Chamorro
  • Ramón López-Palop
  • Alex Sionis
  • Fernando Arós
  • Eulogio García-Fernández
  • Rafael Rubio
  • Felipe Hernández
  • Juan Carlos Tascón
  • José Moreu
  • Amadeu Betriu
  • Antonio Fernández-Ortiz
  • César Morís
  • Ignacio Sánchez de Posada
  • Ángel Cequier
  • Enrique Esplugas
  • Rafael Melgares
  • Francisco Bosa
  • Martín Jesús García-González
  • Román Lezáun
  • José Ramón Carmona
  • José Manuel Vázquez
  • Alfonso Castro-Beiras
  • Joan García Picart
  • José Domínguez de Rozas
  • José Díaz Fernández
  • Felipe Fernández Vázquez
  • Norberto Alonso
  • José Javier Zueco
  • José María San José
  • Alberto San Román
  • Carolina Hernández
  • José María Hernández García
  • Ángel García Alcántara
  • Armando Bethencourt
  • Miquel Fiol
  • Xabier Mancisidor
  • Rafael Ruiz
  • Rafael Hidalgo
  • Nicolás Sobrino
  • Isidoro González Maqueda
  • Alfonso Torres
  • Antonio Amaro
  • Michel Jaquet
چکیده

AIMS To compare primary percutaneous coronary intervention (pPCI) and fibrinolysis in very old patients with ST-segment elevation myocardial infarction (STEMI), in whom head-to-head comparisons between both strategies are scarce. METHODS AND RESULTS Patients ≥75 years old with STEMI <6 h were randomized to pPCI or fibrinolysis. The primary endpoint was a composite of all-cause mortality, re-infarction, or disabling stroke at 30 days. The trial was prematurely stopped due to slow recruitment after enrolling 266 patients (134 allocated to pPCI and 132 to fibrinolysis). Both groups were well balanced in baseline characteristics. Mean age was 81 years. The primary endpoint was reached in 25 patients in the pPCI group (18.9%) and 34 (25.4%) in the fibrinolysis arm [odds ratio (OR), 0.69; 95% confidence interval (CI) 0.38-1.23; P = 0.21]. Similarly, non-significant reductions were found in death (13.6 vs. 17.2%, P = 0.43), re-infarction (5.3 vs. 8.2%, P = 0.35), or disabling stroke (0.8 vs. 3.0%, P = 0.18). Recurrent ischaemia was less common in pPCI-treated patients (0.8 vs. 9.7%, P< 0.001). No differences were found in major bleeds. A pooled analysis with the two previous reperfusion trials performed in older patients showed an advantage of pPCI over fibrinolysis in reducing death, re-infarction, or stroke at 30 days (OR, 0.64; 95% CI 0.45-0.91). CONCLUSION Primary PCI seems to be the best reperfusion therapy for STEMI even for the oldest patients. Early contemporary fibrinolytic therapy may be a safe alternative to pPCI in the elderly when this is not available.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

[Characteristics and mortality following primary percutaneous coronary intervention for acute myocardial infarction in Spain. Results from the TRIANA 1 (TRatamiento del Infarto Agudo de miocardio eN Ancianos) Registry].

INTRODUCTION AND OBJECTIVES Although more elderly patients will experience acute myocardial infarction (AMI) in coming years, the best reperfusion strategy in these patients remains unknown. PATIENTS AND METHOD The Spanish TRIANA (TRatamiento del Infarto Agudo de miocardio eN Ancianos) registry was set up to determine the feasibility of performing a randomized study of percutaneous coronary i...

متن کامل

[Type of treatment and short-term outcome in elderly patients with acute myocardial infarction admitted to hospitals with a primary coronary angioplasty facility. The TRIANA (TRatamiento del Infarto Agudo de miocardio eN Ancianos) Registry].

INTRODUCTION AND OBJECTIVES The nature and outcome of treatment for acute myocardial infarction in elderly patients admitted to Spanish hospitals with primary angioplasty facilities are not well documented. PATIENTS AND METHOD Prospective analysis of registry data on patients > or =75 years old with ST-segment-elevation acute myocardial infarction admitted between April and July 2002 to Spani...

متن کامل

Paclitaxel-eluting Stents in ST-segment Elevation Myocardial Infarction Stents liberadores de paclitaxel en el infarto agudo de miocardio con elevación del segmento ST

ST-segment elevation myocardial infarction (STEMI) is the result of the abrupt occlusion of an epicardial coronary artery. Timely performance of primary percutaneous coronary intervention (PCI) has become the treatment of choice in affected patients. Mechanical reperfusion with implantation of drug-eluting stents (DES) has been associated with improved safety and efficacy compared with balloon ...

متن کامل

[Tratamiento del infarto agudo de miocardio con los nuevos fármacos trombolíticos].

de reducción de mortalidad procedentes de grandes ensa-yos clínicos comparativos con otros trombolíticos.

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره 32  شماره 

صفحات  -

تاریخ انتشار 2011